Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Original Article
M. Husain, A.L. Birkenfeld, M. Donsmark, K. Dungan, F.G. Eliaschewitz, D.R. Franco, O.K. Jeppesen, I. Lingvay, O. Mosenzon, S.D. Pedersen, C.J. Tack, M. Thomsen, T. Vilsbøll, M.L. Warren, and S.C. Bain
N Engl J Med 2019;381:841-851
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, August 29, 2021 - 11:59pm.